Ortin Global Limited (NSE:ORTINGLOBE)

Market Cap	115.95M
Revenue (ttm)	3.84M
Net Income (ttm)	-8.46M
Shares Out	n/a
EPS (ttm)	-1.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,564
Average Volume	64,616
Open	17.00
Previous Close	17.45
Day's Range	16.57 - 17.02
52-Week Range	9.64 - 23.90
Beta	1.37
RSI	50.59
Earnings Date	Aug 13, 2025

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. It operates through Manufacture and Trading segments. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 2
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORTINGLOBE

Financial Performance

In 2024, Ortin Global's revenue was 3.84 million, a decrease of -81.84% compared to the previous year's 21.12 million. Losses were -8.46 million, -89.47% less than in 2023.